Company Profile

SOLV insider trades (13 months) →

Today's multi-factor rank: 109 of 466 · see the ranking

Quant500 Scores

Momentum

5.1/10

Value

5.6/10

Growth

5.2/10

Quality

5.3/10

Multifactor

5.3/10

Market and Valuation

Price & Market

Prev Close Price:$87.53

Open:$87.61

Day's Low:$86.53

Day's High:$89.53

Bid / Ask:-

Market Cap:15.12B

Enterprise Value:20.01B

52-Week Range

52-Week Low:$62.38

52-Week High:$94.16

Current position in 52-week range

52w Low-52w High

50-Day Avg:$85.82

200-Day Avg:$77.66

Volume

Volume Today:2,316,482

Avg Volume (3m):1,124,341

Avg Volume (10d):865,590

52-Week Change:+18.67%

vs S&P 500, 52 weeks:-

Beta:0.69

Valuation Multiples

PER Trailing:10.86

PER Forward:12.29

PEG Ratio:1.22

Price / Book:3.15

Price / Sales (TTM):1.82

EV / Revenue:2.41

EV / EBITDA:17.57

Dividends

Current yield:-

Annual Dividend Rate:-

Dividend Trailing:$0.00

Yield Trailing:0.00%

5-Year Avg Yield:-

Payout Ratio:0.00%

Last Ex-Dividend Date:-

Valuation Context

P/E vs sector (indicative)

Most Recent Quarter:-

Fiscal Year (Next):-

Date Filter (Month):

Loading historical OHLCV database...

Financial Statements TTM (Trailing 12 Months)

Income Statement

Total Revenue (TTM):8.31B

Gross Profit:4.55B

EBITDA:1.14B

Net Income (TTM):1.43B

Rev Growth (YoY):+2.20%

Earnings Growth (YoY):+3.90%

Quarterly earnings growth (YoY):+2.20%

Margins

Gross Margin:-

EBITDA Margin:-

Operating Margin:-

Net Margin:-

Per Share

EPS Trailing (TTM):-

EPS Forward (Est.):$7.23

Revenue Per Share:$47.79

Cash Per Share:-

Book Value:$28.22

Last Dividend:-

Ex-Dividend Date:-

Last Split:-

Balance Sheet & Liquidity

Total cash:403.00M

Total Debt:5.30B

Net Debt (Debt - Cash):4.89B

Debt / Equity:110.31%

Current Ratio:1.02

Quick Ratio:0.50

Cash Flows

Operating Cash Flow:209.00M

Free Cash Flow (FCF):489.00M

FCF Yield (FCF / Market Cap):-

Enterprise Value:20.01B

EV / Revenue:2.41

EV / EBITDA:17.57

Profitability

ROE (Return on Equity):33.96%

ROA (Return on Assets):2.70%

PER Trailing:10.86

PER Forward:12.29

Price / Book:3.15

PEG Ratio:1.22

52-Week Change:+18.67%

S&P 500 change, 52 weeks:+14.80%

Historical Evolution (Last 4 Years)

Income Statement

Balance Sheet

Cash Flow

EPS and Earnings Per Share

Key EPS Metrics

EPS Trailing (TTM):$8.18

EPS Forward (Est.):$7.23

PER Forward:-

PEG Ratio:1.22

Growth and Margins

Earnings Growth YoY:-

Quarterly Earnings Growth YoY:-

Rev Growth YoY:-

Net Margin:-

Gross Margin:-

EBITDA Margin:-

Per Share

Revenue Per Share:$47.79

Cash Per Share:-

Book Value:$28.22

Cash Flows (TTM)

Free Cash Flow:489.00M

Operating Cash Flow:209.00M

EBITDA:1.14B

Total Revenue (TTM):8.31B

Net Income (TTM):1.43B

Fiscal Year (Last):-

EPS Surprise History - Last 4 Quarters

Actual vs. Analyst Estimates · Green = beat expectations · Red = missed

Quarter	Period	Actual EPS	Estimated EPS	Difference	Surprise %	Currency

Ownership Structure

Ownership Distribution

% Insiders:-

% Institutional:-

% Inst. (of Float):-

No. of Institutions:-

Visual distribution

InsidersInstitutionalFree Float

Shares & Short Interest

Shares Outstanding:170,223,729

Float (free shares):144,089,280

Short interest (shares):4,299,252

Short % of float:-

Short Ratio (days to cover):3.68

Short interest, prior month:-

Short Interest Date:-

Governance Score (1=Best, 10=Worst)

Overall risk:-

Audit Risk:-

Board risk:-

Compensation Risk:-

Shareholder rights risk:-

Top Institutional Holders

Position Change: ▲ Increased · ▼ Reduced · = Unchanged

Organization	Report Date	% Shares	No. Shares	Value (USD)	Change %

Top Mutual Funds

Position Change: ▲ Increased ▼ Decreased = Unchanged

Fund	Report Date	% Shares	No. Shares	Value (USD)	Change %

Recent Insider Trades

Executive / Insider	Title	Date	Action	Shares

Options Chain

Expiration Date:

CALLS

Strike	Last	Bid	Ask	Vol.	O.I.	IV

PUTS

Strike	Last	Bid	Ask	Vol.	O.I.	IV

Solventum Corporation (SOLV) SEC filings: 10-K, 10-Q and 8-K

Direct links to financial reports filed with the SEC.

Type	Date	Official link
10-Q	2026-08-05	View filing ↗
8-K	2026-07-20	View filing ↗
8-K	2026-06-05	View filing ↗
SD	2026-05-29	View filing ↗
8-K	2026-05-27	View filing ↗
8-K	2026-05-20	View filing ↗
8-K	2026-05-05	View filing ↗
DEFA14A	2026-03-27	View filing ↗
8-K	2026-03-24	View filing ↗
10-K	2026-02-27	View filing ↗

Company and Executive Profile

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs. The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is headquartered in Eagan, Minnesota.

General Information

Headquarters:United States

City:Eagan

Employees:20,584

Sector:Healthcare

Industry:Medical Instruments & Supplies

Website:-

Key Executives

Name	Title	Age	Total pay
Mr. Bryan C. Hanson	CEO & Director	58	4.93M
Mr. Wayde D. McMillan	Executive VP & CFO	55	1.97M
Ms. Amy Landucci	Chief Information & Digital Officer	50	1.66M
Ms. Marcela A. Kirberger	Chief Corporate & Legal Affairs Officer & Corporate Secretary	58	1.60M
Ms. Heather L. Knight	Chief Commercial Officer	53	2.26M
Mr. Neil C. Zieselman	Senior VP, Controller & Chief Accounting Officer	49	-
Ms. Amy Wakeham	Senior Vice President of Investor Relations & External Finance Communications	-	-
Ms. Kate Dobbs	Chief Communications & Corporate Marketing Officer	-	-

You have seen the engine room

Few finance sites let you get this far, and none we know of also shows you where its knowledge ends. If this way of working convinces you, the thing almost nobody catches in time can reach you by email: the big insider buys — executives and major shareholders putting in their own money — the same day they report them to the SEC, with the Form 4 linked. It takes three steps and none of them costs anything: create the account, confirm the email we send you, then switch the alert on in your profile (the icon at the top right). It starts off and it goes off again with the same click. Along the way all three are saved: your simulator portfolios, your personal portfolio and your Academy progress, synced across devices.

No card. No spam.

Solventum Corporation (SOLV): Quantitative Analysis

Name: Factor scores for Solventum Corporation (SOLV)
Creator: Quant500
License: https://quant500.com/legal

Solventum Corporation (SOLV) — Healthcare — Medical Instruments & Supplies. SOLV is in the S&P 500 today. Model factor scores and market data, recalculated every trading day.

So far in 2026, SOLV has returned +12.1% against +12.2% for the S&P 500 (SPY): total return, dividends included on both sides, from Dec 31, 2025 to Sep 18, 2026.

SOLV ranks 109 of 466 on today's multifactor score, and 15 of the 55 Healthcare companies that score. Its strongest factor is value (Z 0.35, ranked 118 of 494); its weakest is momentum (Z 0.08, ranked 204 of 497). Each factor ranks only the companies with data for it, and the multifactor score only those with all four: that is why the totals differ.

Factor scores

The Z-Score is how many standard deviations the company sits from the index average: 0 is average, positive is better than average, negative is worse.

Factor	Z-Score	Rank
Multifactor	0.195	109 of 466 ↑3
Momentum	0.075	204 of 497 ↑4
Value	0.353	118 of 494 ↓6
Quality	0.204	142 of 473 =
Growth	0.149	133 of 494 =

Market data

Metric	Value
Price	$88.84
Market Cap	15.12B
P/E	10.86
Revenue (last 12 months)	8.31B
Price / book	3.15
Book value per share	$28.22
52-week range	$62.38 – $94.16
Beta	0.69
Average volume	1,124,341
Shares outstanding	170.22M
Short interest (% of float)	2.98% (as of Aug 31, 2026)

When does SOLV report earnings? 9 of its last 10, after the close →

What are SOLV insiders doing? 65 transactions filed with the SEC, of them 1 buy, the last one on Sep 1, 2026 →

Data as of Sep 18, 2026. Source: point-in-time SEC fundamentals and closing prices. Method and formulas are on the home page.

Company Profile

Market and Valuation

Price & Market

52-Week Range

Volume

Valuation Multiples

Dividends

Valuation Context

Financial Statements TTM (Trailing 12 Months)

Income Statement

Margins

Per Share

Balance Sheet & Liquidity

Cash Flows

Profitability

Historical Evolution (Last 4 Years)

Income Statement

Balance Sheet

Cash Flow

EPS and Earnings Per Share

Key EPS Metrics

Growth and Margins

Per Share

Cash Flows (TTM)

EPS Surprise History - Last 4 Quarters

Ownership Structure

Ownership Distribution

Shares & Short Interest

Governance Score (1=Best, 10=Worst)

Top Institutional Holders

Top Mutual Funds

Recent Insider Trades

Options Chain

CALLS

PUTS

Sentiment Metrics

Expected move

Solventum Corporation (SOLV) SEC filings: 10-K, 10-Q and 8-K

Company and Executive Profile

General Information

Key Executives

You have seen the engine room

Solventum Corporation (SOLV): Quantitative Analysis

Factor scores

Market data